Vince DeVita, MD

The Yale Cancer Center Lifetime Achievement Award is the highest honors bestowed within our organization. Our committee had very little trouble in determining that the 2017 Award should go to Vincent DeVita, Jr, MD, recognizing his work developing the first successful chemotherapy treatment for Hodgkin's lymphoma, a breakthrough that was heralded by the American Society of Clinical Oncology as the top research advance in half a century.

During his career, Dr. DeVita served as Director of the National Cancer Institute, as President of the American Cancer Society, and as Director of the Yale Cancer Center.

"As one of oncology’s leading figures, Dr. DeVita knows what cancer looks like from the lab bench and the bedside," commented Dr. Roy Herbst during the ceremony. "It is truly an honor to give this award to Dr. DeVita!"


(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.